The link between Dali Rayson and insomnia
Insomnia is a common sleep disorder characterized by difficulty falling asleep, maintaining sleep, or waking up early, which seriously affects the patient's quality of life. In recent years, as people's pace of life accelerates and stress increases, the incidence of insomnia has gradually increased. There are many kinds of drugs for treating insomnia, but how to find a drug that is both effective and has fewer side effects has always been a difficult problem in clinical medicine. Daridorexant, as a new type of sleep regulating drug, has received widespread attention around the world.
Daliramin is an oral non-benzodiazepine drug that regulates sleep mainly by selectively inhibiting the wake-promoting neurotransmitter - orexin (orexin) receptor. The orexin system plays an important role in regulating the sleep-wake cycle, by balancing the brain's wake and sleep states. Normally, Orexin promotes arousal and wakefulness, but when this system is overactivated, it can lead to insomnia or other sleep disorders. By inhibiting Orexin receptors 1 and 2, DaliRasen helps patients maintain their natural sleep cycle and improve sleep quality.
Unlike traditional hypnotic drugs, Dalitraxen has fewer side effects and does not interfere with the natural regulation of sleep. Although traditional insomnia treatment drugs such as benzodiazepines can effectively induce sleep, they are often accompanied by side effects such as memory impairment, drug resistance, and dependence. As a new type of drug, Dalitrazolin has low dependence and drug resistance, has less interference with cognitive function, and is safer to use.
Research shows that DaliRasen can not only help insomnia patients fall asleep quickly, but also maintain deep sleep and improve overall sleep quality. In addition, it interferes less with circadian rhythms, allowing patients to wake up in the morning feeling more alert and without the drug-induced "hangover." Therefore, DaliRasen provides a new and effective treatment option for patients with insomnia.
Reference materials:https://www.quviviq.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)